Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety and effectiveness of A-prexa for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedA Randomized, Double Blind Study to Evaluate the Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoThe Switch Study - Efficacy of Early Antipsychotic Switch Versus Maintenance in Patients With Schizophrenia Poorly Responding to Two Weeks of Antipsychotic Treatment
This study has finished and is no longer accepting participants.
In Munich
This study has finished and is no longer accepting participants.
Multiple locations, including StamfordThis study has finished and is no longer accepting participants.
In Los AngelesAn Open-Label Study Changing Generic Clozapine Formulation to FazaClo® (Clozapine, USP) Orally Disintegrating Tablets in Stable Patients With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In New YorkEstimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
This study ended early.
In NashvilleResearchers studied isradipine to find out how it affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
In New YorkExenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Worcester
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
This study has finished and is no longer accepting participants.
In BethesdaEffect of Nicotine Agonist Galantamine Added to High Potency Medications for Cognitive Function in Patients With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In BostonA Randomized, Double-Blind, Parallel-Group, Fixed Dose, Clinical Trial of Quetiapine 600 mg/Day vs 1200 mg/Day for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including New YorkWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.